Open AccessSerum Fibroblast Growth Factor-23 and Risk of Incident Chronic Kidney Disease in Older Community-Dwelling Women
Author(s) -
Richard D. Semba,
Jeffrey C. Fink,
Kai Sun,
Anne Rentoumis Cappola,
Mansi Dalal,
Candace Crasto,
Luigi Ferrucci,
Linda P. Fried
Publication year - 2011
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.08070811
Subject(s) - medicine , fibroblast growth factor 23 , kidney disease , risk factor , gerontology , parathyroid hormone , calcium
Elevated circulating fibroblast growth factor 23 (FGF23) predicts progression of CKD, but it is unknown whether circulating FGF23 independently predicts incident CKD. This study aimed to determine whether circulating FGF23 predicts incident CKD in community-dwelling women.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom